Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Authors: Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, Brian Angus, Stephan Becker et al.